JOB DESCRIPTION: At Abbott, were committed to helping people live their best possible life through the power of health. For more than 125 years, weve brought new products and technologies to the world in nutrition, diagnostics, medical
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)